In general, the presence of TLSs is associated with the most aggressive breast cancer subtypes, such as TNBC (triple-negative breast cancer), HER2 enriched and luminal B, while tumours without TLSs tend to be luminal A [13]. The gene discussed is ERBB2; the disease is neoplasm.